DeutschNewstral
Article
The Jerusalem Post (JPost.com) on 2021-03-15 12:15
Gilead, Merck collaborate to develop long-acting HIV treatment
Related news
- BMerck and Gilead Are Joining Forces on a Long-Acting HIV Therapybarrons.com
Gilead and Merck Join Forces to Develop Long-Acting HIV Treatmentwsj.com
Gilead, Merck pause trial of once-a-week HIV drug combobizjournals.com- MMerck shares dip after surprise patent loss to Gileadmarketwatch.com
Jury: Gilead Owes Merck $200M in Damages Over Drug Patentsmemphisdailynews.com
Jury: Gilead owes Merck $200M in damages over drug patentsdailyherald.com- Gilead pays startup $123M to develop longer-lasting HIV pillbizjournals.com
- MMerck to develop dengue vaccine with Brazilian nonprofitmarketwatch.com
- BMerck and Gilead Sciences Sign Deals to Aid India's Covid-19 Fightbarrons.com
- Aiming at HIV treatments that last for months, Gilead aligns with Merckbizjournals.com
- FGSK agrees deal to develop longer-acting HIV drugsft.com
- Gilead pays Watertown startup Lyndra $123M to develop longer-lasting HIV pillbizjournals.com
- MGilead shares drop after new UnitedHealth program incentivizes cheaper HIV medsmarketwatch.com
- MGilead says four late-stage trials of HIV drug combination met primary endpointsmarketwatch.com
- KHuman Immunodeficiency Virus (HIV) Market Will Increase Demand In Forecast By 2026 |Gilead, GlaxoSmithKline, Johnson & Johnson, Merck, AbbVie, etcksusentinel.com
- MModerna and Merck will collectively develop a most cancers vaccine for high-risk melanoma sufferersmvtelegraph.com
Md. groups to benefit from Gilead Sciences’ $12.6M grant to improve HIV landscape for Black women, girls thedailyrecord.com- BMerck Could Be a Big Winner in the HIV Prevention Market, Analysts Saybarrons.com
- LBiotechnology Market 2021-2026 Size and Share, Recent Enhancements and Regional Analysis | Key Companies: Johnson & Johnson, Roche, Pfizer, Merck, Sanofi, AstraZeneca, Gilead, CELGENE CORPORATION, …liverpoolstudentmedia.com